Primary care network
Primary CaRe Study
The I-MOVE primary care studies started in the 2008–09 influenza season. Study sites in various countries have carried out studies every influenza season since then, using the test-negative case control study design. Each season we pool the individual studies in the multicentre study and measure pooled influenza vaccine effectiveness (VE) by influenza (sub)type.
We also measure VE by age group, by clade/genetic variant (since 2015–16), by previous vaccination, by time since vaccination and by influenza vaccine type (since 2012–13).
For more information please see the generic protocol and the laboratory protocol, as well as our scientific publications. The links below form part of the restricted site that only members of the study site teams can access via a dedicated login and password. If you have any questions, please do not hesitate to contact us.
In the 2019–20 season study sites in the following countries are taking part in the I-MOVE primary care multicentre study: Croatia, France, Germany, Ireland, Portugal, Romania, Spain, the Netherlands and Sweden.
If you are a study site team member, please login above or on the login page.
Study site protocols
Have to contact us? Please click on the link below